Hexavest’s Labcorp LH Stock Holding History

Hexavest’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-185,596	Closed	-$20.2M	–	438
2020 Q1	$20.2M	Buy	185,596 +3,764	+2%	+$542K	0.35%	95
2019 Q4	$26.4M	Buy	+181,832	New	+$26.3M	0.32%	111

Other funds holding LH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Hexavest's LH Position: Q2 2020 in Review

Hexavest sold out of Labcorp (LH) in Q2 2020, closing a stake of 185,596 shares — an estimated $20.2M sold.

Hexavest first reported a position in LH in Q4 2019 and held it in 2 quarters. The position peaked at $26.4M in Q4 2019. 798 funds tracked by Wall St. Rank hold LH as of Q2 2020.

Hexavest reported no remaining Labcorp position as of Q2 2020 after selling out during the quarter.
Hexavest sold 185,596 Labcorp shares in Q2 2020, an estimated $20.2M.
Hexavest first reported a position in Labcorp in Q4 2019 and held it in 2 quarters.
Hexavest's Labcorp position peaked at $26.4M in Q4 2019.
798 funds tracked by Wall St. Rank held Labcorp as of Q2 2020.

Based on Hexavest's 13F filing for Q2 2020, filed 10 Jul 2020.